Latest Financials News

Robex Resources has reached a pivotal milestone at its Kiniéro Gold Project in Guinea by delivering first ore to the mill, setting the stage for first gold production expected this month.

Arafura Rare Earths has completed the second tranche of its $475 million capital raise, issuing over 1.25 billion shares and raising $351.6 million before costs. The company also awaits results from a retail share purchase plan that could add another $50 million.

The Australian Treasurer has approved Hanwha Corporation’s increase of its direct equity stake in Austal Limited from 9.9% to 19.9%, setting the stage for potential strategic partnerships as Austal rides a wave of record revenues and defence contracts.

APC Minerals Limited has announced a pro-rata renounceable entitlement offer to raise approximately $1.38 million by issuing new shares at a low price, aiming to bolster its capital base. Eligible shareholders can subscribe for 13 new shares for every 11 held, with a closing date set for early January 2026.

Medallion Metals has completed a Feasibility Study for its Ravensthorpe Gold Project, confirming robust economics and a clear pathway to near-term gold and copper production leveraging existing infrastructure in Western Australia.

Dateline Resources reaffirms its Colosseum Gold-REE Project metrics and economics while navigating ongoing legal proceedings involving its CEO and rare earth tenements in the US.

Metallium Limited has resumed trading on the ASX following news of a significant collaboration and funding deal with a US partner to advance its critical-metals recovery technology.

4DMedical has locked in $30.2 million through an underwriting agreement ensuring full exercise of its listed options, lifting its cash reserves to $63.7 million and setting the stage for a pivotal year in commercialising its CT – VQ™ technology.

Vita Life Sciences forecasts solid sales and profit growth for FY2025, driven by strong performances in Malaysia and Singapore, while cautiously managing challenges in China exports.

Voltaic Strategic Resources confirms a significant 1.2km surface rare earth element and gallium anomaly at its Soren prospect within the Paddys Well Project, setting the stage for an extensive 2026 drilling and geophysical campaign.

Acrux Limited has sold the US registration and distribution rights for its Prilocaine 2.5% and Lidocaine 2.5% cream for US$550,000, redirecting resources towards its growing Hormone Replacement Therapy portfolio.

IRIS Metals Limited has voluntarily suspended trading of its shares on the ASX pending a significant capital raising announcement expected next week.